Berkeley Capital Partners LLC reduced its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 33.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 45,830 shares of the real estate investment trust's stock after selling 23,455 shares during the quarter. Berkeley Capital Partners LLC's holdings in Healthpeak Properties were worth $929,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. AdvisorNet Financial Inc increased its stake in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock valued at $44,000 after acquiring an additional 563 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in Healthpeak Properties by 10.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust's stock valued at $133,000 after purchasing an additional 598 shares in the last quarter. Commerzbank Aktiengesellschaft FI increased its stake in Healthpeak Properties by 3.9% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 21,002 shares of the real estate investment trust's stock valued at $420,000 after purchasing an additional 797 shares in the last quarter. Mirador Capital Partners LP raised its holdings in shares of Healthpeak Properties by 2.8% during the fourth quarter. Mirador Capital Partners LP now owns 33,132 shares of the real estate investment trust's stock valued at $672,000 after purchasing an additional 901 shares during the period. Finally, Concurrent Investment Advisors LLC boosted its position in shares of Healthpeak Properties by 10.1% during the 4th quarter. Concurrent Investment Advisors LLC now owns 10,117 shares of the real estate investment trust's stock worth $205,000 after purchasing an additional 927 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.
Healthpeak Properties Price Performance
DOC stock traded up $0.42 during midday trading on Monday, reaching $20.45. The company had a trading volume of 3,344,719 shares, compared to its average volume of 4,630,015. The firm has a 50-day moving average price of $20.24 and a 200-day moving average price of $21.16. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market capitalization of $14.30 billion, a P/E ratio of 58.42, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 1 year low of $17.45 and a 1 year high of $23.26.
Healthpeak Properties Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were given a $0.305 dividend. The ex-dividend date of this dividend was Friday, February 14th. This is a positive change from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 5.97%. Healthpeak Properties's payout ratio is 348.57%.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on DOC. Robert W. Baird decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Scotiabank decreased their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Mizuho lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Finally, StockNews.com upgraded shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a report on Saturday. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $23.92.
Check Out Our Latest Research Report on Healthpeak Properties
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
